BusinessDelcath Announces Initiation of Registrational Trial of Melphalan/HDS in Intrahepatic CholangiocarcinomaBy Nasdaq OMXMay 7, 2018, 12:02 PM UTC
BusinessASLAN Pharmaceuticals Sponsors Cholangiocarcinoma Foundation Annual Conference 2018By Nasdaq OMXJan 31, 2018, 6:00 AM UTC
BusinessBile Duct Cancer (Cholangiocarcinoma) Treatment Market to show Incremental Opportunity of US$ 144.2 Mn by 2025 - Persistence Market ResearchBy Nasdaq OMXDec 21, 2017, 8:32 AM UTC
BusinessArQule Reports Fourth Quarter and Full Year 2015 Financial ResultsBy Nasdaq OMXFeb 29, 2016, 12:00 PM UTC
